Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)

Past Federal grant forecast Posted

Opportunity number
PAR-27-119
Agency
Applications expected due
Award size
Not on record

Opportunity facts

Expected posting
Assistance listings
Funding instrument
Not on record
Category
  • Health
Eligible applicants
  • Other
  • 501(c)(3) Nonprofits
  • Tribal Governments (Federally Recognized)
  • Public or Indian Housing Auth.
  • Non-501(c)(3) Nonprofits
  • Tribal Organizations (Not Federally Recognized)
  • City/Township Governments
  • County Governments
  • Special District Governments
  • Small Businesses
  • State Governments
  • Higher Education Inst. (Public)
  • Independent School Districts
  • Higher Education Inst. (Private)
  • For Profit Organizations
Points of contact

Opportunity details come from Grants.gov. Updated .

About this opportunity

Written by GovTribe AI ·

The National Institutes of Health National Human Genome Research Institute (NHGRI) is soliciting applications for access to the Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource, an NIH-wide initiative that provides genomic services and statistical genetics support to advance gene identification and specimen characterization through next-generation sequencing and high-throughput genotyping.

Eligible applicants include higher education institutions (public and private), state and local governments, small businesses, nonprofit organizations (501(c)(3) and non-501(c)(3)), tribal governments and organizations, federal agencies, faith-based and community-based organizations, non-domestic entities, and U.S. territories or possessions. Clinical trials are not allowed under this mechanism (X01).

CIDR specializes in genomic platforms and services that cannot be efficiently performed in individual investigator laboratories, offering the most current technologies alongside statistical genetic support. The resource is designed to support 1) identification of genes or genetic modifications contributing to human health and disease or 2) enhanced classification and characterization of well-phenotyped specimens through genotype or next-generation sequence data addition.

This opportunity operates under the Human Genome Research program (CFDA 93.172), administered by NHGRI. Current service information and capabilities are available at https://cidr.jhmi.edu. Applications undergo competitive scientific and technical merit review, with scoring and advisory council consideration determining award selection based on scientific merit, program relevance, and program balance. Individual project grants typically require nine months from submission to award of funds.

Forecast synopsis

The Center for Inherited Disease Research (CIDR) carries out high-throughput genotyping and sequencing and supports statistical genetics services designed to 1) aid identification of genes or genetic modifications that contribute to human health and disease or 2) enhance the classification and characterization of well-phenotyped specimens by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, services, and statistical genetic support. This is an NIH-wide initiative that is administered by NHGRI. Information about current services offered can be accessed via: https://cidr.jhmi.edu.


Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login